| Literature DB >> 29456084 |
X Shawn Liu1, Hao Wu2, Marine Krzisch1, Xuebing Wu1, John Graef3, Julien Muffat1, Denes Hnisz1, Charles H Li4, Bingbing Yuan1, Chuanyun Xu1, Yun Li1, Dan Vershkov5, Angela Cacace3, Richard A Young4, Rudolf Jaenisch6.
Abstract
Fragile X syndrome (FXS), the most common genetic form of intellectual disability in males, is caused by silencing of the FMR1 gene associated with hypermethylation of the CGG expansion mutation in the 5' UTR of FMR1 in FXS patients. Here, we applied recently developed DNA methylation editing tools to reverse this hypermethylation event. Targeted demethylation of the CGG expansion by dCas9-Tet1/single guide RNA (sgRNA) switched the heterochromatin status of the upstream FMR1 promoter to an active chromatin state, restoring a persistent expression of FMR1 in FXS iPSCs. Neurons derived from methylation-edited FXS iPSCs rescued the electrophysiological abnormalities and restored a wild-type phenotype upon the mutant neurons. FMR1 expression in edited neurons was maintained in vivo after engrafting into the mouse brain. Finally, demethylation of the CGG repeats in post-mitotic FXS neurons also reactivated FMR1. Our data establish that demethylation of the CGG expansion is sufficient for FMR1 reactivation, suggesting potential therapeutic strategies for FXS.Entities:
Keywords: CGG repeats; CRISPR/Cas9; DNA methylation editing; FMR1 reactivation; fragile X syndrome
Mesh:
Substances:
Year: 2018 PMID: 29456084 PMCID: PMC6375087 DOI: 10.1016/j.cell.2018.01.012
Source DB: PubMed Journal: Cell ISSN: 0092-8674 Impact factor: 41.582